U.S Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026
The U.S secondary hyperparathyroidism (SHPT) treatment market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 7.06 billion by 2026, exhibiting a... Read More
Region : Global | Published Date: Nov, 2019 | Report ID: FBI101664 | Status : Published